TY - JOUR
T1 - Mapping prohormone processing by proteases in human enteroendocrine cells using genetically engineered organoid models
AU - Beumer, Joep
AU - Bauzá-Martinez, Julia
AU - Veth, Tim S.
AU - Geurts, Veerle
AU - Boot, Charelle
AU - Gilliam-Vigh, Hannah
AU - Poulsen, Steen S.
AU - Knop, Filip K.
AU - Wu, Wei
AU - Clevers, Hans
N1 - Publisher Copyright:
Copyright © 2022 the Author(s). Published by PNAS.
PY - 2022/11/16
Y1 - 2022/11/16
N2 - Enteroendocrine cells (EECs) secrete hormones in response to ingested nutrients to control physiological processes such as appetite and insulin release. EEC hormones are synthesized as large proproteins that undergo proteolytic processing to generate bioactive peptides. Mutations in EEC-enriched proteases are associated with endocrinopathies. Due to the relative rarity of EECs and a paucity of in vitro models, intestinal prohormone processing remains challenging to assess. Here, human gut organoids in which EECs can efficiently be induced are subjected to CRISPR-Cas9–mediated modification of EEC-expressed endopeptidase and exopeptidase genes. We employ mass spectrometry–based analyses to monitor peptide processing and identify glucagon production in intestinal EECs, stimulated upon bone morphogenic protein (BMP) signaling. We map the substrates and products of major EECs endo- and exopeptidases. Our studies provide a comprehensive description of peptide hormones produced by human EECs and define the roles of specific proteases in their generation.
AB - Enteroendocrine cells (EECs) secrete hormones in response to ingested nutrients to control physiological processes such as appetite and insulin release. EEC hormones are synthesized as large proproteins that undergo proteolytic processing to generate bioactive peptides. Mutations in EEC-enriched proteases are associated with endocrinopathies. Due to the relative rarity of EECs and a paucity of in vitro models, intestinal prohormone processing remains challenging to assess. Here, human gut organoids in which EECs can efficiently be induced are subjected to CRISPR-Cas9–mediated modification of EEC-expressed endopeptidase and exopeptidase genes. We employ mass spectrometry–based analyses to monitor peptide processing and identify glucagon production in intestinal EECs, stimulated upon bone morphogenic protein (BMP) signaling. We map the substrates and products of major EECs endo- and exopeptidases. Our studies provide a comprehensive description of peptide hormones produced by human EECs and define the roles of specific proteases in their generation.
KW - CRISPR-Cas9
KW - enteroendocrine cells
KW - intestinal organoids
KW - peptidomics
KW - prohormone processing
KW - Endopeptidases/metabolism
KW - Organoids
KW - Humans
KW - Peptide Hydrolases/genetics
KW - Insulin/metabolism
KW - Enteroendocrine Cells/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85141346727&partnerID=8YFLogxK
U2 - 10.1073/pnas.2212057119
DO - 10.1073/pnas.2212057119
M3 - Article
C2 - 36343264
AN - SCOPUS:85141346727
SN - 0027-8424
VL - 119
SP - e2212057119
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 46
M1 - e2212057119
ER -